Public risk perception of non-prescription medicines and information disclosure during consultations : a suitable target for intervention?
| dc.contributor.author | Fielding, Shona | |
| dc.contributor.author | Slovic, Paul | |
| dc.contributor.author | Johnston, Marie | |
| dc.contributor.author | Lee, Amanda J | |
| dc.contributor.author | Bond, Christine M | |
| dc.contributor.author | Watson, Margaret C | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Statistics | en |
| dc.date.accessioned | 2019-01-10T00:05:34Z | |
| dc.date.available | 2019-01-10T00:05:34Z | |
| dc.date.embargoedUntil | 2019-01-10 | |
| dc.date.issued | 2018-10-01 | |
| dc.description | This work was supported by the Chief Scientist Office, Scottish Executive Health Department (CZH/4/376). The views expressed in this paper are those of the authors and may not represent the views of the funding organisation. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 799453 | |
| dc.identifier | 113061812 | |
| dc.identifier | e516be13-2f22-4252-85dc-acc41d3e576d | |
| dc.identifier | 29318694 | |
| dc.identifier | 29318694 | |
| dc.identifier | 85040371540 | |
| dc.identifier.citation | Fielding, S, Slovic, P, Johnston, M, Lee, A J, Bond, C M & Watson, M C 2018, 'Public risk perception of non-prescription medicines and information disclosure during consultations : a suitable target for intervention?', International Journal of Pharmacy Practice, vol. 26, no. 5, pp. 423-432. https://doi.org/10.1111/ijpp.12433 | en |
| dc.identifier.doi | 10.1111/ijpp.12433 | |
| dc.identifier.iss | 5 | en |
| dc.identifier.issn | 0961-7671 | |
| dc.identifier.other | ORCID: /0000-0002-4865-9061/work/159078202 | |
| dc.identifier.other | ORCID: /0000-0003-0124-4827/work/175113957 | |
| dc.identifier.uri | http://hdl.handle.net/2164/11757 | |
| dc.identifier.vol | 26 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | International Journal of Pharmacy Practice | en |
| dc.subject | health knowledge | en |
| dc.subject | self-care | en |
| dc.subject | risk assessment | en |
| dc.subject | non-prescription drugs | en |
| dc.subject | self-medication | en |
| dc.subject | RS Pharmacy and materia medica | en |
| dc.subject | Chief Scientist Office (CSO) | en |
| dc.subject | CZH/4/376 | en |
| dc.subject.lcc | RS | en |
| dc.title | Public risk perception of non-prescription medicines and information disclosure during consultations : a suitable target for intervention? | en |
| dc.type | Journal article | en |
